The Blood of the Lamb.

@article{Steensma2009TheBO,
  title={The Blood of the Lamb.},
  author={David P. Steensma},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2009},
  volume={27 16},
  pages={
          2729-31
        }
}
  • D. Steensma
  • Published 1 June 2009
  • Art
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Peter De Vries (1910-1993)—writer for the New Yorker, Poetry editor, once widely acknowledged as the top American comic novelist of his era—was best known for his clever wordplay, irreverent humor, and extended riffs on a broad range of human foibles. But despite De Vries’ reputation for puckish wit and for the skewering bon mot, his greatest novel is a tragedy—one that is all the more haunting because it is stuffed with autobiographical detail. The Blood of the Lamb, published in 1961… 

References

SHOWING 1-10 OF 23 REFERENCES
A tribute to Sidney Farber – the father of modern chemotherapy
TLDR
His landmark study, published in 1948, demonstrated that a number of folic acid antagonists produced temporary remissions in children with acute undifferentiated leukaemia, leading to the development and use of other chemotherapeutic agents, either singly or, more effectively, in combination for treating childhood and adult malignancies.
Joe Burchenal and the birth of combination chemotherapy
TLDR
Success in treating lymphoid malignancies in children led him to develop treatment regimens for other more resistant cancers, and as an advocate of collaborative working he introduced multimodal therapy to tackle bulky or metastatic cancers.
History of the treatment of childhood ALL: a paradigm for cancer cure.
  • J. Simone
  • Medicine
    Best practice & research. Clinical haematology
  • 2006
Down syndrome in Down House: trisomy 21, GATA1 mutations, and Charles Darwin.
TLDR
The village of Downe is nestled in the rolling hills of Kent just 16 miles from the city, and the chief attraction for nonresidents is Down House, a Grade II-listed mansion on the outskirts of London.
Long‐term survivors in acute leukemia and Burkitt's tumor
TLDR
The authors suggest that in the United States all abdominal and extranodal lymphoma in children, except Hodgkin's disease, be treated as is Burkitt's tumor in Africa with Cytoxan, 40 mg/kg every 3 weeks, plus obliterative radiotherapy where disease appears localized.
Clinical evaluation of a new antimetabolite, 6-mercaptopurine, in the treatment of leukemia and allied diseases.
TLDR
A new antimetabolite, 6-mercaptopurine, has been shown to produce good clinical and hematologic remissions in fifteen out of forty-five children with acute leukemia, and this compound would appear to be of fundamental as well as practical interest.
THE VINCA ALKALOIDS: A NEW CLASS OF ONCOLYTIC AGENTS.
TLDR
A phytochemical investigation of the plant Vinca rosea Linn has demonstrated that a number of alkaloidal substances can be obtained with antitumor activity, including vinblastine, vincristine, and vinrosidine, which are capable of prolonging and/or “curing” mice of the P-1534 leukemia.
The comparison of 6-mercaptopurine with the combination of 6-mercaptopurine and azaserine in the treatment of acute leukemia in children: results of a cooperative study.
TLDR
In 125 cases of previously untreated acute leukemia in children, no significant difference was seen in the percentage of complete remissions obtained when 6-mercaptopurine was used alone or when 6 -mercaptoburine and azaserine were used in combination.
“Total therapy” studies of acute lymphocytic leukemia in children. Current results and prospects for cure
TLDR
With currently available modalities of therapy, the prospects for cure appear bright, and if current trends in these studies continue, the authors can expect a 50% long‐term leukemia‐free remission rate.
A comparative study of two regimens of combination chemotherapy in acute leukemia.
TLDR
No indication was obtained, therefore, that patients who attained remission were subjected to a greater toxic hazard, in order to achieve the therapeutic benefits observed, than those who did not remit.
...
1
2
3
...